Scott Tarriff - 05 Jan 2024 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
10%+ Owner
Signature
/s/ Scott Tarriff
Issuer symbol
EGRX
Transactions as of
05 Jan 2024
Transactions value $
-$22,172
Form type
4
Filing time
09 Jan 2024, 17:00:02 UTC
Previous filing
03 Nov 2023
Next filing
29 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability -$22.2K -4.32K -0.79% $5.13 541K 05 Jan 2024 Direct F1
holding EGRX Common Stock 993K 05 Jan 2024 By Tarriff 2016 Generation Skipping Exempt Family Trust DTD 12/28/2016 F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units on January 5, 2024.
F2 Shares held by the Tarriff 2016 Generation Skipping Exempt Family Trust DTD 12/28/2016 (the "Trust") for the benefit of the Reporting Person's spouse and children. The Reporting Person does not have investment control over the shares held by the Trust and disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest, if any, therein.